Source Feed: CFRA - 580 - Ottawa
Publication Date: October 24, 2025 - 18:03
Hour 4 of Ottawa Now for Fri. October 24th, 2025
October 24, 2025
Earlier this week, Brett Jelley was in Toronto to witness George Springer’s Game 7 heroics live and in-person. And when the World Series reaches Game 2 on Saturday, he’s going to be cheering on the boys once more! We reconnect with the Ottawa native in Hour 4. Then, we preview tonight’s CTV Ottawa supper-hour newscast with Kimberley Fowler and Jackie Perez. And finally, if you are planning a trip to the local cinema this weekend, Matt Demers has got you covered with his Weekly Movie Picks!
Doctors are calling on provinces to bolster addiction treatment services in response to growing opioid use among young people, a crisis they fear will escalate for decades to come if immediate action is not taken.In a Canadian Medical Association Journal (CMAJ) editorial published Monday, physicians Shannon Charlebois and Shawn Kelly say the escalation of opioid use among youth is being overlooked. Existing addiction services, they say, are also inadequate to meet the needs of young people with opioid use disorder, or OUD.
October 27, 2025 - 00:01 | Alanna Smith | The Globe and Mail
The Alberta government is expected to introduce back-to-work legislation on Monday to force striking teachers to return to classrooms after three weeks, raising fears among labour advocates that the province will invoke the Charter’s notwithstanding clause to override workers’ rights. More than 750,000 students have been out of class since Oct. 6, after negotiations between the Alberta Teachers’ Association and the province broke down.
October 26, 2025 - 21:24 | Meera Raman | The Globe and Mail
Health Canada has for the first time approved a disease-modifying drug for Alzheimer’s disease, a watershed moment that offers hope for patients but does not guarantee that the complex and expensive intravenous therapy will be widely available in this country. The federal regulator on Friday granted a conditional authorization for lecanemab, an antibody drug that can slow the progression of the disease for some people with mild cognitive impairment or early-stage dementia owing to Alzheimer’s.
October 26, 2025 - 21:08 | Kelly Grant | The Globe and Mail
Comments
Be the first to comment